Delivery Order HHSN261201600022I-HHSN26100002
Award Date 4/10/17
Potential Completion Date 6/30/22
Potential Value $408K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Pittsburgh, PA 15213, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $208,940.00 firm-fixed-price delivery order contract to the University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh. The contract is for pharmacokinetic studies with selected anticancer compounds in NSG mice, with a period of performance from September 13, 2019 to September 12, 2024. This contract is under a larger...
- This is a $128,971.00 fixed-price delivery order awarded by the National Cancer Institute to the University of Pittsburgh, a state-related research university in Pennsylvania. The contract is for pharmacokinetic and oral bioavailability studies in rats to support the development of cancer treatments. It is a task order under the Pharmacokinetic and Pharmacology Evaluations for Cancer Patients Indefinite Delivery Contract, which allows the National Cancer Institute to rapidly initiate new...
- The Department of Health and Human Services (HHS) National Cancer Institute awarded a $67,683 firm-fixed-price delivery order contract to the University of Pittsburgh to provide analytical support and pharmacokinetic (PK) sample analysis for preclinical pharmacology studies of agents being developed for cancer patients. The contract has a period of performance from September 16, 2019 to September 15, 2024 and is part of the larger Pharmacokinetic and Pharmacology Evaluations for Cancer...
- This is a federal contract award to the University of Pittsburgh - Of The Commonwealth System Of Higher Education, doing business as The University of Pittsburgh, for pharmacokinetic and oral bioavailability studies in rats. The $459,445.00 cost-no-fee delivery order contract was awarded by the National Cancer Institute, a civilian agency. The award does not have a set-aside designation. The University of Pittsburgh is a state-related research university in Pittsburgh, Pennsylvania that...
- This is a $110,445.12 firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS), to the University of Pittsburgh. The contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the NCI's cancer research efforts. The contract has no set-aside designation, indicating it was competed openly. The University...
- This federal contract award was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the University of Pittsburgh, a state-related research university in Pennsylvania. The $122,754.24 firm fixed-price contract was awarded on May 4, 2010 under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery contract (IDC). The contract is for the provision of tissue samples and data from various types of cancer to support the...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), to the University of Pittsburgh for tissue samples and data from various cancer types to support the Cancer Genome Atlas (TCGA) program. The $285,310.98 contract was awarded on May 12, 2010 under the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract, with a period of performance through March 31, 2015. The contract does...
- This is a $142,143.34 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the University of Pittsburgh for the NCI's Cancer Genome Atlas (TCGA) program. The contract is to provide tissue samples and data from various types of cancer to support the TCGA program, which aims to construct a comprehensive "atlas" of the molecular changes involved in human cancers. The award is not set aside and is part of a larger IDIQ contract titled the "NCI Cancer...
- This $116,898 firm-fixed-price purchase order contract was awarded to the University of Pittsburgh by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services. The contract has a completion date of June 30, 2024 and does not have a set-aside designation. The University of Pittsburgh is a major recipient of federal research grants and contracts across a wide range of scientific and medical disciplines. Pitt frequently...
- This is a federal contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of Pittsburgh. The contract, valued at $27,605.09, is for the determination of 5-fluoro-2'-deoxycytidine (FDCYD), selected downstream metabolites, and tetrahydrouridine (THU) levels in human samples. The period of performance is from May 1, 2018, to August 31, 2021. This contract is a delivery order under the Pharmacokinetic and Pharmacology...